The Memphis Grizzlies aren't in the NBA playoffs, but fans have plenty of reason to pay attention, with Mike Conley Jr. and Cam Payne still in it.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...